Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. APLT.NASDAQ

Applied Therapeutics Inc (APLT NASDAQ) stock market data APIs

$5.26 0.04(0.8%) as of July 26, 2024
Price chart is built with Anychart

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Applied Therapeutics Inc Financial Data Overview

5.22
5.26
-
5.32
5.155
1.18-9.39
594 M
114 M
-477 000
-0.67
1.992
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'APLT',
Type: 'Common Stock',
Name: 'Applied Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000DD0489',
ISIN: NULL,
CUSIP: NULL,
CIK: '1697532',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2019-05-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Applied Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue -477 000
  • EBITDA -74 768 496
  • Earnings Per Share -1.91
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Applied Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.16

Get Applied Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Applied Therapeutics Inc latest news via APIs

13 Best Booming Stocks to Buy Right Now

In this article, we will take a detailed look at the13 Best Booming Stocks to Buy Right Now. For a quick overview of such stocks, read our article 5 Best Booming Stocks to Buy Right Now. Despite late...

We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. By way of example, Applied Therapeutics (NASDAQ:APLT) has seen its sh...
Do you have any questions?
support@eodhistoricaldata.com